Rockwell Medical Q1 net sales $17.3M (-8% YoY); guides FY26 gross margin 18-22%

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

Exchange Act, unless such subsequent filing specifically references this Form 8-K. --- EX-99.1 (EX-99.1) --- To Our Shareholders, The Company’s first quarter 2026 revenue of $435.8 million increased slightly from the record first quarter 2025 revenue by $1.0 million, or 0.2%. This growth was driven by consistent demand in the Utility segment, where revenue

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

2026) -- The Dixie Group, Inc. (OTCQB: DXYN) today reported financial results for the quarter ended March 28, 2026. For the first quarter of 2026, the Company had net sales of $59,380,000 as compared to $62,990,000 in the same quarter of 2025. The Company had an operating income of $3,264,000 in the first quarter of 2026 compared to an operating income of $11,000

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

Sonida Senior Living Announces First Quarter 2026 Results DALLAS, Texas – May 11, 2026 – Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2026.

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

the company's scale and our focus on operational efficiency across eXp World Holdings,” said Jesse Hill, Chief Financial Officer of eXp World Holdings. “We generated revenue of $1.0 billion and Adjusted EBITDA of $4.1 million, an 88% improvement that further strengthened our financial position. More recently, we executed the strategic NextHome acquisition using cash

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

Total revenue grew to $72 million in the first quarter of 2026, up 53% from the prior year period.

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

Consolidated net sales of $903 million, an increase of 2.3% compared to the prior year; • Consolidated comparable sales growth of 1.3%; • Global e-commerce sales increased 13% to $108 million, representing 12% of net sales; • GAAP gross margin expansion of 70 basis points to 52.7%; • Adjusted Gross Margin expansion of 80 basis points to 52.8%; • GAAP selling, general and administrative expenses of $404 million, an increase of $14 million compared to the prior year; • Adjusted Selling, General and Administrative Expenses of $404 million, an increase of $20 million compared to the prior year; • GAAP operating earnings of $72 million and GAAP operating margin of 8.0%; • Adjusted Operating Earnings of $73 million and Adjusted Operating Margin of 8.1%; • GAAP diluted net earnings per share of $0.43, an increase of 13% compared to the prior year;

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Key Highlights (vs. Year-Ago Period) 1,2 • Net income for the quarter increased to $8.1 million compared to $4.5 million. • Adjusted EBITDA for the quarter increased to $36.4 million compared to $30.9 million. • Net cash provided by operating activities for the quarter was

This filing

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive

Comparable filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.